Guangzhou Kingmed Diagnostics Hits Day Low Amid Price Pressure at CNY 28.10

Guangzhou Kingmed Diagnostics Group Co., Ltd. experienced a notable decline today, with the stock dropping by 3.75% and reaching an intraday low of CNY 28.10. This performance stands in contrast to the China Shanghai Composite, which gained 0.59% on the same day. Over the past week, Guangzhou Kingmed has shown a slight increase of 0.86%, but its longer-term performance reveals significant challenges. The stock has decreased by 11.38% over the past year and has faced a staggering decline of 74.82% over the last five years. The company's net sales for the first half of the year were reported at CNY 3,071.65 million, reflecting a decrease of 18.69%, while net profit showed a loss of CNY 51.82 million, a decline of 146.08%. Despite a high dividend yield of 3.07%, the company has consistently underperformed against the benchmark, with negative results reported for the last ten consecutive quarters. The current market cap stands at CNY 13,387 million, categorizing it as a large-cap entity within the pharmaceuticals and biotechnology industry.